Mpharm Holger Kroenig
About Mpharm Holger Kroenig
Mpharm Holger Kroenig is the Disease Area Head and Medical Director of Oncology and Hematology at Bristol-Myers Squibb in New York, with over 20 years of experience in the medical field.
Current Role at Bristol-Myers Squibb
Mpharm Holger Kroenig is currently serving as the Disease Area Head, Medical Director Oncology and Hematology at Bristol-Myers Squibb in New York, New York, United States. He has been leading the oncology and hematology disease area at the company since February 2016. His expertise includes extensive experience in medical affairs and clinical practice within the field of oncology and hematology.
Previous Experience at Gilead Sciences
From 2014 to 2015, Mpharm Holger Kroenig worked at Gilead Sciences as the Associate Director of Oncology, Medical Affairs. During his tenure, he was involved in significant projects within oncology, contributing to the advancement of medical affairs in this specialty area.
Role at PRA Health Sciences
Mpharm Holger Kroenig served as Medical Director, Hematology and Oncology - Medical Affairs at PRA Health Sciences from 2012 to 2014. During this period, he worked on significant projects that furthered the understanding and treatment of diseases in hematology and oncology.
Tenure at Klinikum Rechts der Isar TU Muenchen
Between 2005 and 2012, Mpharm Holger Kroenig was a Resident and Post-Doctoral Fellow in Hematology and Oncology at Klinikum Rechts der Isar TU Muenchen. This seven-year period allowed him to gain in-depth clinical experience and expertise in both fields.
Educational Background and Research Experience
Mpharm Holger Kroenig holds a Doctor of Medicine and Doctorates from Ludwig-Maximilians Universität München, having studied there from 1998 to 2004. Additionally, he completed a research internship in immunobiology at the Department of Immunobiology at Yale University in 2003. Kroenig’s academic and research background solidified his strong foundation in immunobiology, further enhancing his capability in oncology and hematology.